WallStreetZenWallStreetZen

NASDAQ: GLSI
Greenwich Lifesciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their GLSI stock forecasts and price targets.

Forecast return on equity

Is GLSI forecast to generate an efficient return?

Company
-950.74%
Industry
95.86%
Market
345.67%
GLSI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GLSI forecast to generate an efficient return on assets?

Company
-545.67%
Industry
25.68%
GLSI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GLSI earnings per share forecast

What is GLSI's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.12
Avg 2 year Forecast
-$1.51
Avg 3 year Forecast
-$1.50

GLSI revenue forecast

What is GLSI's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$8.9M

GLSI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GLSI$8.13N/AN/A
SEER$2.00N/AN/A
SRZN$13.50N/AN/A
IKT$1.56N/AN/A
ONCY$1.04$7.33+605.10%Strong Buy
View Top Biotech Stocks

Greenwich Lifesciences Stock Forecast FAQ

What is GLSI's earnings growth forecast for 2025-2027?

(NASDAQ: GLSI) Greenwich Lifesciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 76.95%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 104.55%.

Greenwich Lifesciences's earnings in 2025 is -$19,475,704.On average, 4 Wall Street analysts forecast GLSI's earnings for 2025 to be -$15,474,135, with the lowest GLSI earnings forecast at -$16,971,810, and the highest GLSI earnings forecast at -$13,674,430. On average, 3 Wall Street analysts forecast GLSI's earnings for 2026 to be -$20,914,812, with the lowest GLSI earnings forecast at -$20,094,623, and the highest GLSI earnings forecast at -$21,529,954.

In 2027, GLSI is forecast to generate -$20,773,496 in earnings, with the lowest earnings forecast at -$19,958,849 and the highest earnings forecast at -$21,384,481.

If you're new to stock investing, here's how to buy Greenwich Lifesciences stock.

What is GLSI's revenue growth forecast for 2025-2027?

(NASDAQ: GLSI) Greenwich Lifesciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 294.46%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.42%.

Greenwich Lifesciences's revenue in 2025 is $0.On average, 4 Wall Street analysts forecast GLSI's revenue for 2025 to be $0, with the lowest GLSI revenue forecast at $0, and the highest GLSI revenue forecast at $0. On average, 3 Wall Street analysts forecast GLSI's revenue for 2026 to be $0, with the lowest GLSI revenue forecast at $0, and the highest GLSI revenue forecast at $0.

In 2027, GLSI is forecast to generate $123,651,761 in revenue, with the lowest revenue forecast at $118,802,672 and the highest revenue forecast at $127,295,504.

What is GLSI's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: GLSI) forecast ROA is -545.67%, which is lower than the forecast US Biotechnology industry average of 25.68%.

What is GLSI's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: GLSI) Greenwich Lifesciences's current Earnings Per Share (EPS) is -$1.46. On average, analysts forecast that GLSI's EPS will be -$1.12 for 2025, with the lowest EPS forecast at -$1.23, and the highest EPS forecast at -$0.99. On average, analysts forecast that GLSI's EPS will be -$1.51 for 2026, with the lowest EPS forecast at -$1.45, and the highest EPS forecast at -$1.55. In 2027, GLSI's EPS is forecast to hit -$1.50 (min: -$1.44, max: -$1.54).

What is GLSI's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: GLSI) forecast ROE is -950.74%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.